Cargando…

Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial

While current pharmacotherapies are efficacious, there remain a clear shortfall between symptom remission and functional recovery. With the explosion in our understanding of the biology of these disorders, the time is ripe for the investigation of novel therapies. Recently depression is conceptualiz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dean, Olivia May, Maes, Michael, Ashton, Melanie, Berk, Lesley, Kanchanatawan, Buranee, Sughondhabirom, Atapol, Tangwongchai, Sookjareon, Ng, Chee, Dowling, Nathan, Malhi, Gin S., Berk, MIchael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293162/ https://www.ncbi.nlm.nih.gov/pubmed/25598820 http://dx.doi.org/10.9758/cpn.2014.12.3.180

Ejemplares similares

Speaker 2: Olivia Dean, Australia
por: OM, Dean, et al.
Publicado: (2016)

Adjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response
por: Walker, Adam J., et al.
Publicado: (2022)

Personality disorder and functioning in major depressive disorder: a nested study within a randomized controlled trial
por: Kavanagh, Bianca E., et al.
Publicado: (2019)

Episodic memory and delayed recall are significantly more impaired in younger patients with deficit schizophrenia than in elderly patients with amnestic mild cognitive impairment
por: Kanchanatawan, Buranee, et al.
Publicado: (2018)

Posttraumatic mental health establishment of the Tsunami survivors in Thailand
por: Thavichachart, Nuntika, et al.
Publicado: (2009)

How to Construct a Bottom-Up Nomothetic Network Model and Disclose Novel Nosological Classes by Integrating Risk Resilience and Adverse Outcome Pathways with the Phenome of Schizophrenia
por: Maes, Michael, et al.
Publicado: (2020)

Mixed Methods Thematic Analysis of a Randomised Controlled Trial of Adjunctive Mitochondrial Agents for Bipolar Depression
por: Russell, Samantha E., et al.
Publicado: (2022)

Lower Nerve Growth Factor Levels in Major Depression and Suicidal Behaviors: Effects of Adverse Childhood Experiences and Recurrence of Illness
por: Maes, Michael, et al.
Publicado: (2023)

Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive Garcinia mangostana Linn. (Mangosteen) Pericarp for Schizophrenia
por: Turner, Alyna, et al.
Publicado: (2019)

First Episode Psychosis and Schizophrenia Are Systemic Neuro-Immune Disorders Triggered by a Biotic Stimulus in Individuals with Reduced Immune Regulation and Neuroprotection
por: Maes, Michael, et al.
Publicado: (2021)

A Novel Pathway Phenotype of Temporal Lobe Epilepsy and Comorbid Psychiatric Disorders: Results of Precision Nomothetic Medicine
por: Maes, Michael, et al.
Publicado: (2022)

A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
por: Berk, Michael, et al.
Publicado: (2019)

Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
por: Berk, Michael, et al.
Publicado: (2019)

Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial
por: Ashton, Melanie M., et al.
Publicado: (2018)

Lithium therapy and its interactions
por: Malhi, Gin S, et al.
Publicado: (2020)

Minocycline for the treatment of mental health and neurological conditions: study protocol of a systematic review and meta-analysis
por: Bortolasci, Chiara C, et al.
Publicado: (2020)

Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-Analysis
por: Panizzutti, Bruna, et al.
Publicado: (2023)

In Vitro Effects of Cannabidiol on Activated Immune–Inflammatory Pathways in Major Depressive Patients and Healthy Controls
por: Rachayon, Muanpetch, et al.
Publicado: (2022)

The Immune Profile of Major Dysmood Disorder: Proof of Concept and Mechanism Using the Precision Nomothetic Psychiatry Approach
por: Maes, Michael, et al.
Publicado: (2022)

Does Post-traumatic Stress Disorder Impact Treatment Outcomes within a Randomised Controlled Trial of Mitochondrial Agents for Bipolar Depression?
por: Russell, Samantha E., et al.
Publicado: (2023)

Sequence variation and linkage disequilibrium in the GABA transporter-1 gene (SLC6A1) in five populations: implications for pharmacogenetic research
por: Hirunsatit, Rungnapa, et al.
Publicado: (2007)

A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol
por: Maier, Alice, et al.
Publicado: (2020)

Minocycline as adjunct therapy for a male patient with deficit schizophrenia
por: Chen, Xiaohua, et al.
Publicado: (2018)

Adverse Childhood Experiences Predict the Phenome of Affective Disorders and These Effects Are Mediated by Staging, Neuroimmunotoxic and Growth Factor Profiles
por: Maes, Michael, et al.
Publicado: (2022)

N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial
por: Arancini, Lauren, et al.
Publicado: (2019)

Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial
por: Berk, Michael, et al.
Publicado: (2012)

Studies on Haloperidol and Adjunctive α-Mangostin or Raw Garcinia mangostana Linn Pericarp on Bio-Behavioral Markers in an Immune-Inflammatory Model of Schizophrenia in Male Rats
por: Lotter, Jana, et al.
Publicado: (2020)

Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)
por: Husain, Muhammad Ishrat, et al.
Publicado: (2020)

The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia
por: Ashton, Melanie M., et al.
Publicado: (2019)

The Effect of Adjunctive Mangosteen Pericarp on Cognition in People With Schizophrenia: Secondary Analysis of a Randomized Controlled Trial
por: Marx, Wolfgang, et al.
Publicado: (2021)

Mitochondrial Agents for Bipolar Disorder
por: Pereira, Círia, et al.
Publicado: (2018)

The Impact of N-acetylcysteine on Major Depression: Qualitative Observation and Mixed Methods Analysis of Participant Change during a 12-week Randomised Controlled Trial
por: Russell, Samantha E., et al.
Publicado: (2023)

Changing dynamics of psychoneuroimmunology during the COVID-19 pandemic
por: Debnath, Monojit, et al.
Publicado: (2020)

Nutraceuticals and nutritional supplements for the treatment of bipolar disorder: protocol for a systematic review
por: Ashton, Melanie M, et al.
Publicado: (2019)

Systemic antimicrobial therapy (minocycline) as an adjunct to non-surgical approach to recurrent chronic generalized gingival hyperplasia
por: Khatri, Parag M., et al.
Publicado: (2014)

Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial
por: Husain, Muhammad I., et al.
Publicado: (2015)

Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses
por: Morris, Gerwyn, et al.
Publicado: (2015)

Can the Open Label Placebo Rationale Be Optimized?
por: Heiss, Uwe, et al.
Publicado: (2021)

Mindfulness Training for People With Dementia and Their Caregivers: Rationale, Current Research, and Future Directions
por: Berk, Lotte, et al.
Publicado: (2018)

Tobacco Use in Bipolar Disorder
por: Thomson, Daniel, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2tg7betfcejc5qkmt35k40m3kf